Primex Clinical Laboratories, Inc.
11
Martin R. Barash
10/10/2023
11/19/2024
Yes
v
Assigned to: Martin R. Barash Chapter 11 Voluntary Asset |
|
Debtor Primex Clinical Laboratories, Inc.
16742 Stagg Street Suite 120 Van Nuys, CA 91406 LOS ANGELES-CA Tax ID / EIN: 95-4574505 |
represented by |
Garrick A Hollander
Winthrop Golubow Hollander, LLP 1301 Dove Street, Suite 500 Newport Beach, CA 92660 949-720-4150 Fax : 949-720-4111 Email: ghollander@wghlawyers.com Peter W Lianides
Winthrop Golubow Hollander, LLP 1301 Dove Street, Suite 500 Newport Beach, CA 92660 949-720-4100 Fax : 949-720-4111 Email: plianides@wghlawyers.com Matthew J Stockl
Winthrop Golubow Hollander, LLP 1301 Dove Street Suite 500 Newport Beach, CA 92660 949-720-4100 Email: matthew.stockl@dinsmore.com |
U.S. Trustee United States Trustee (SV)
915 Wilshire Blvd, Suite 1850 Los Angeles, CA 90017 (213) 894-6811 |
represented by |
Russell Clementson
915 Wilshire Blvd., Suite 1850 Los Angeles, CA 90017 213-894-4505 Fax : 213-894-0276 Email: russell.clementson@usdoj.gov |
| Date Filed | # | Docket Text |
|---|---|---|
| 11/20/2024 | Receipt of Amending Schedules D and/or E/F (Official Form 106D, 106E/F, 206D, or 206E/F) (Fee)( 1:23-bk-11446-MB) [misc,amdsch] ( 34.00) Filing Fee. Receipt number A57686452. Fee amount 34.00. (re: Doc# 216) (U.S. Treasury) (Entered: 11/20/2024) | |
| 11/19/2024 | 216 | Summary of Schedules (Official Form B6 - Pg1) Amended, Declaration re: Amended Schedules, Non-Individual: List of Creditors Who Have the 20 Largest Unsecured Claims and Are Not Insiders (Form 104 or 204) Amended, Summary of Assets and Liabilities for Non-Individual (Official Form 106Sum or 206Sum) Amended, Amended Schedule A/B Non-Individual: Property (Official Form 106A/B or 206A/B) Amended, Amending Schedules (D) (E/F) Amended Fee Amount $34, Schedule G Non-Individual: Executory Contracts and Unexpired Leases (Official Form 106G or 206G) Amended, Schedule H Non-Individual: Your Codebtors (Official Form 106H or 206H) Amended, Statement of Financial Affairs for Non-Individual Filing for Bankruptcy (Official Form 107 or 207) Amended, List of Creditors (Master Mailing List of Creditors) Amended Filed by Debtor Primex Clinical Laboratories, Inc. (RE: related document(s)43 Declaration Under Penalty of Perjury for Non-Individual Debtors (Official Form 202), Chapter 11 or Chapter 9: List of Creditors Who Have the 20 Largest Unsecured Claims and Are Not Insiders (Form 104 or 204), List of Equity Security Holders, Statement of Related Cases (LBR Form 1015-2.1), Summary of Assets and Liabilities (Official Form 106Sum or 206Sum), Schedule A/B: Property (Official Form 106A/B or 206A/B), Schedule D: Creditors Who Have Claims Secured by Property (Official Form 106D or 206D), Schedule E/F: Creditors Who Have Unsecured Claims (Official Form 106F or 206F), Schedule G: Executory Contracts and Unexpired Leases (Official Form 106G or 206G), Schedule H: Your Codebtors (Official Form 106H or 206H), Statement of Financial Affairs (Official Form 107 or 207) (Official Form 107 or 207), Disclosure of Compensation of Atty for Debtor (Official Form 2030), Verification of Master Mailing List of Creditors (LBR F1007-1), Corporate Ownership Statement, Corp Resolution Auth Filing). (Hollander, Garrick) (Entered: 11/19/2024) |
| 11/19/2024 | 215 | Notice to Filer of Error and/or Deficient Document Incorrect docket event was used to file this document. (RE: related document(s)214 Amended List of Creditors (Fee) filed by Debtor Primex Clinical Laboratories, Inc., Amending Schedules D and/or E/F (Official Form 106D, 106E/F, 206D, or 206E/F) (Fee), Schedule A/B: Property (Official Form 106A/B or 206A/B), Schedule H: Your Codebtors (Official Form 106H or 206H), Schedule G: Executory Contracts and Unexpired Leases (Official Form 106G or 206G), Verification of Master Mailing List of Creditors (LBR F1007-1)) (RT) (Entered: 11/19/2024)THE FILER IS INSTRUCTED TO RE-FILE THE DOCUMENT USING THE CORRECT DOCKET EVENT. |
| 11/18/2024 | Receipt of Amending Schedules D and/or E/F (Official Form 106D, 106E/F, 206D, or 206E/F) (Fee)( 1:23-bk-11446-MB) [misc,amdsch] ( 34.00) Filing Fee. Receipt number A57676882. Fee amount 34.00. (re: Doc# 214) (U.S. Treasury) (Entered: 11/18/2024) | |
| 11/18/2024 | Receipt of Amended List of Creditors (Fee)( 1:23-bk-11446-MB) [misc,amdcm] ( 34.00) Filing Fee. Receipt number A57676882. Fee amount 34.00. (re: Doc# 214) (U.S. Treasury) (Entered: 11/18/2024) | |
| 11/18/2024 | 214 | Amendment to List of Creditors. Fee Amount $34, Amending Schedules (D) (E/F) Fee Amount $34, Amended Schedule A/B Non-Individual: Property (Official Form 106A/B or 206A/B) , Schedule H Non-Individual: Your Codebtors (Official Form 106H or 206H) , Schedule G Non-Individual: Executory Contracts and Unexpired Leases (Official Form 106G or 206G) , Verification of Master Mailing List of Creditors (LBR Form F1007-1) Filed by Debtor Primex Clinical Laboratories, Inc.. (Hollander, Garrick) (Entered: 11/18/2024) |
| 11/18/2024 | 213 | Chapter 11 Monthly Operating Report for the Month Ending: 10/31/2024 Filed by Debtor Primex Clinical Laboratories, Inc.. (Attachments: # 1 October 2024 Statements) (Hollander, Garrick) (Entered: 11/18/2024) |
| 11/18/2024 | 212 | Chapter 11 Monthly Operating Report for the Month Ending: 09/30/2024 Filed by Debtor Primex Clinical Laboratories, Inc.. (Attachments: # 1 September 2024 Statements) (Hollander, Garrick) (Entered: 11/18/2024) |
| 11/18/2024 | 211 | Chapter 11 Monthly Operating Report for the Month Ending: 08/31/2024 Filed by Debtor Primex Clinical Laboratories, Inc.. (Attachments: # 1 Redacted Statements - August) (Hollander, Garrick) (Entered: 11/18/2024) |
| 11/14/2024 | 210 | Notice Notice Of Filing Of Primex Clinical Laboratories Litigation Trust Agreement In Support Of The Debtors Third Amended Chapter 11 Plan Of Reorganization Filed by Debtor Primex Clinical Laboratories, Inc. (RE: related document(s)186 Emergency motion Debtors Emergency Motion For Order Authorizing Debtor To Make Non-Material Modifications To Debtors Second Amended Chapter 11 Plan Of Reorganization; Memorandum Of Points And Authorities In Support Of Motion [Declaration Of Garrick A. Hollander In Support Of The Motion Is Filed Concurrently Herewith] Filed by Debtor Primex Clinical Laboratories, Inc., 189 Amended Chapter 11 Plan Debtors Third Amended Chapter 11 Plan Of Reorganization Filed by Debtor Primex Clinical Laboratories, Inc. (RE: related document(s)164 Amended Chapter 11 Plan Debtors Second Amended Chapter 11 Plan Of Reorganization Filed by Debtor Primex Clinical Laboratories, Inc. (RE: related document(s)158 Amended Chapter 11 Plan Debtors First Amended Chapter 11 Plan Of Reorganization Filed by Debtor Primex Clinical Laboratories, Inc. (RE: related document(s)148 Chapter 11 Plan of Reorganization Filed by Debtor Primex Clinical Laboratories, Inc..).).).). (Hollander, Garrick) (Entered: 11/14/2024) |